These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 23271752)

  • 1. The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Karapanagiotidis S; Wong C; Eikelis N; Richards KL; Lee G; Nestel PJ; Dixon JB; Lambert GW; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2013 Feb; 98(2):E227-37. PubMed ID: 23271752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone treatment enhances the sympathetic nervous system response to oral carbohydrate load in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Richards K; Dixon JB; Schlaich MP; Lambert EA
    Metabolism; 2015 Jul; 64(7):797-803. PubMed ID: 25827058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndrome.
    Straznicky NE; Grima MT; Lambert EA; Sari CI; Eikelis N; Nestel PJ; Phillips SE; Hering D; Karapanagiotidis S; Dixon JB; Schlaich MP; Lambert GW
    J Clin Endocrinol Metab; 2015 Apr; 100(4):1544-50. PubMed ID: 25590214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndrome.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert GW; Nestel PJ; Karapanagiotidis S; Wong C; Richards K; Marusic P; Dixon JB; Schlaich MP; Lambert EA
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1701-7. PubMed ID: 24937541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects.
    Straznicky NE; Grima MT; Sari CI; Eikelis N; Lambert EA; Nestel PJ; Esler MD; Dixon JB; Chopra R; Tilbrook AJ; Schlaich MP; Lambert GW
    Diabetes; 2012 Oct; 61(10):2506-16. PubMed ID: 22664956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in peripheral vascular resistance predicts improvement in insulin clearance following weight loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Kobayashi D; Hering D; Mariani JA; Dixon JB; Nestel PJ; Karapanagiotidis S; Schlaich MP; Lambert GW
    Cardiovasc Diabetol; 2015 Aug; 14():113. PubMed ID: 26297500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome.
    Straznicky NE; Lambert GW; Masuo K; Dawood T; Eikelis N; Nestel PJ; McGrane MT; Mariani JA; Socratous F; Chopra R; Esler MD; Schlaich MP; Lambert EA
    Am J Clin Nutr; 2009 Jan; 89(1):27-36. PubMed ID: 19056585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of dietary weight loss on sympathetic activity and cardiac risk factors associated with the metabolic syndrome.
    Straznicky NE; Lambert EA; Lambert GW; Masuo K; Esler MD; Nestel PJ
    J Clin Endocrinol Metab; 2005 Nov; 90(11):5998-6005. PubMed ID: 16091482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obesity, type 2 diabetes, and impaired insulin-stimulated blood flow: role of skeletal muscle NO synthase and endothelin-1.
    Reynolds LJ; Credeur DP; Manrique C; Padilla J; Fadel PJ; Thyfault JP
    J Appl Physiol (1985); 2017 Jan; 122(1):38-47. PubMed ID: 27789766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
    Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
    Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of endothelial function and sympathetic nervous system activity along the glucose continuum in individuals with differing metabolic risk profiles and low dietary sodium intake.
    Baqar S; Straznicky NE; Lambert G; Kong YW; Dixon JB; Jerums G; Ekinci EI; Lambert E
    BMJ Open Diabetes Res Care; 2019; 7(1):e000606. PubMed ID: 31114697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults.
    Lambert E; Sari CI; Dawood T; Nguyen J; McGrane M; Eikelis N; Chopra R; Wong C; Chatzivlastou K; Head G; Straznicky N; Esler M; Schlaich M; Lambert G
    Hypertension; 2010 Sep; 56(3):351-8. PubMed ID: 20625075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy.
    Olsen MH; Hjerkinn E; Wachtell K; Høieggen A; Bella JN; Nesbitt SD; Fossum E; Kjeldsen SE; Julius S; Ibsen H
    J Hum Hypertens; 2003 May; 17(5):305-11. PubMed ID: 12756402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components.
    Straznicky NE; Grima MT; Eikelis N; Nestel PJ; Dawood T; Schlaich MP; Chopra R; Masuo K; Esler MD; Sari CI; Lambert GW; Lambert EA
    J Clin Endocrinol Metab; 2011 Mar; 96(3):E503-8. PubMed ID: 21177786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal systolic and diastolic myocardial function in obese asymptomatic adolescents.
    Batalli-Këpuska A; Bajraktari G; Zejnullahu M; Azemi M; Shala M; Batalli A; Ibrahimi P; Jashari F; Henein MY
    Int J Cardiol; 2013 Oct; 168(3):2347-51. PubMed ID: 23416017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular diastolic function and cardiometabolic factors in obese normotensive children.
    Porcar-Almela M; Codoñer-Franch P; Tuzón M; Navarro-Solera M; Carrasco-Luna J; Ferrando J
    Nutr Metab Cardiovasc Dis; 2015 Jan; 25(1):108-15. PubMed ID: 25439663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac abnormalities as a new manifestation of nonalcoholic fatty liver disease: echocardiographic and tissue Doppler imaging assessment.
    Goland S; Shimoni S; Zornitzki T; Knobler H; Azoulai O; Lutaty G; Melzer E; Orr A; Caspi A; Malnick S
    J Clin Gastroenterol; 2006; 40(10):949-55. PubMed ID: 17063117
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential sympathetic activation in muscle and skin neural districts in the metabolic syndrome.
    Grassi G; Quarti-Trevano F; Seravalle G; Dell'Oro R; Dubini A; Mancia G
    Metabolism; 2009 Oct; 58(10):1446-51. PubMed ID: 19515393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable Attenuation of Sympathetic Nervous System Activity in Obese Subjects with Normal Glucose Tolerance, Impaired Glucose Tolerance, and Treatment Naïve Type 2 Diabetes following Equivalent Weight Loss.
    Straznicky NE; Grima MT; Sari CI; Lambert EA; Phillips SE; Eikelis N; Mariani JA; Kobayashi D; Hering D; Dixon JB; Lambert GW
    Front Physiol; 2016; 7():516. PubMed ID: 27857694
    [No Abstract]   [Full Text] [Related]  

  • 20. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
    Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
    Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.